ID   TAB2_RAT                Reviewed;         693 AA.
AC   Q5U303;
DT   07-MAR-2006, integrated into UniProtKB/Swiss-Prot.
DT   07-MAR-2006, sequence version 2.
DT   24-JUL-2024, entry version 145.
DE   RecName: Full=TGF-beta-activated kinase 1 and MAP3K7-binding protein 2;
DE   AltName: Full=Mitogen-activated protein kinase kinase kinase 7-interacting protein 2;
DE   AltName: Full=TGF-beta-activated kinase 1-binding protein 2;
GN   Name=Tab2; Synonyms=Map3k7ip2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Adapter required to activate the JNK and NF-kappa-B signaling
CC       pathways through the specific recognition of 'Lys-63'-linked
CC       polyubiquitin chains by its RanBP2-type zinc finger (NZF). Acts as an
CC       adapter linking MAP3K7/TAK1 and TRAF6 to 'Lys-63'-linked polyubiquitin
CC       chains. The RanBP2-type zinc finger (NZF) specifically recognizes Lys-
CC       63'-linked polyubiquitin chains unanchored or anchored to the substrate
CC       proteins such as RIPK1/RIP1 and RIPK2: this acts as a scaffold to
CC       organize a large signaling complex to promote autophosphorylation of
CC       MAP3K7/TAK1, and subsequent activation of I-kappa-B-kinase (IKK) core
CC       complex by MAP3K7/TAK1 (By similarity). Regulates the IL1-mediated
CC       translocation of NCOR1 out of the nucleus (By similarity). Involved in
CC       heart development (By similarity). {ECO:0000250|UniProtKB:Q99K90,
CC       ECO:0000250|UniProtKB:Q9NYJ8}.
CC   -!- SUBUNIT: Interacts with MAP3K7 and TRAF6. Identified in the TRIKA2
CC       complex composed of MAP3K7, TAB1 and TAB2. Binds 'Lys-63'-linked
CC       polyubiquitin chains (By similarity). Interacts with NCOR1 and HDAC3 to
CC       form a ternary complex (By similarity). Interacts (via C-terminal) with
CC       NUMBL (via PTB domain). Interacts (via the C-terminus) with DYNC2I2
CC       (via WD domains). Interacts with RBCK1. Interacts with TRIM5 (By
CC       similarity). Interacts with TRIM38 (via B30.2/SPRY domain), leading to
CC       its translocation to lysosomes and degradation (By similarity).
CC       {ECO:0000250|UniProtKB:Q99K90, ECO:0000250|UniProtKB:Q9NYJ8}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:Q9NYJ8};
CC       Peripheral membrane protein {ECO:0000250|UniProtKB:Q9NYJ8}. Endosome
CC       membrane {ECO:0000250|UniProtKB:Q9NYJ8}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:Q9NYJ8}. Lysosome membrane
CC       {ECO:0000250|UniProtKB:Q9NYJ8}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:Q9NYJ8}. Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:Q9NYJ8}. Note=Following IL1 stimulation,
CC       translocation occurs from the membrane to cytosol. Interaction with
CC       TRIM38 promotes translocation from cytosol to endosome and lysosome.
CC       {ECO:0000250|UniProtKB:Q9NYJ8}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q5U303-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q5U303-2; Sequence=VSP_017421;
CC   -!- DOMAIN: The RanBP2-type zinc finger (NZF) mediates binding to two
CC       consecutive 'Lys-63'-linked ubiquitins. {ECO:0000250|UniProtKB:Q9NYJ8}.
CC   -!- PTM: SUMOylated by TRIM60; leading to inhibition of MAPK/NF-kappaB
CC       activation and the innate immune response.
CC       {ECO:0000250|UniProtKB:Q9NYJ8}.
CC   -!- PTM: Ubiquitinated; following IL1 stimulation or TRAF6 overexpression.
CC       Ubiquitination involves RBCK1 leading to proteasomal degradation.
CC       Ubiquitinated at Lys-611 by TRIM45 leading to proteasomal degradation.
CC       {ECO:0000250|UniProtKB:Q9NYJ8}.
CC   -!- PTM: Degraded in a lysosome-dependent manner following interaction with
CC       TRIM38. {ECO:0000250|UniProtKB:Q9NYJ8}.
CC   -!- PTM: Phosphorylated. {ECO:0000250|UniProtKB:Q9NYJ8}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC085788; AAH85788.1; -; mRNA.
DR   EMBL; CK364963; -; NOT_ANNOTATED_CDS; mRNA.
DR   RefSeq; NP_001012062.1; NM_001012062.1.
DR   AlphaFoldDB; Q5U303; -.
DR   BMRB; Q5U303; -.
DR   SMR; Q5U303; -.
DR   BioGRID; 258943; 1.
DR   IntAct; Q5U303; 1.
DR   STRING; 10116.ENSRNOP00000021904; -.
DR   iPTMnet; Q5U303; -.
DR   PhosphoSitePlus; Q5U303; -.
DR   PaxDb; 10116-ENSRNOP00000021904; -.
DR   Ensembl; ENSRNOT00000021905.7; ENSRNOP00000021904.3; ENSRNOG00000016054.8. [Q5U303-1]
DR   Ensembl; ENSRNOT00000061999.6; ENSRNOP00000058709.2; ENSRNOG00000016054.8. [Q5U303-2]
DR   Ensembl; ENSRNOT00055015658; ENSRNOP00055012571; ENSRNOG00055009246. [Q5U303-1]
DR   Ensembl; ENSRNOT00060009560; ENSRNOP00060007183; ENSRNOG00060005760. [Q5U303-1]
DR   Ensembl; ENSRNOT00065041631; ENSRNOP00065034022; ENSRNOG00065024260. [Q5U303-1]
DR   UCSC; RGD:1309527; rat. [Q5U303-1]
DR   AGR; RGD:1309527; -.
DR   RGD; 1309527; Tab2.
DR   eggNOG; ENOG502QRAY; Eukaryota.
DR   GeneTree; ENSGT00940000158473; -.
DR   HOGENOM; CLU_025065_1_0_1; -.
DR   InParanoid; Q5U303; -.
DR   OMA; GPTFIHH; -.
DR   OrthoDB; 5400650at2759; -.
DR   PhylomeDB; Q5U303; -.
DR   TreeFam; TF332021; -.
DR   Reactome; R-RNO-168638; NOD1/2 Signaling Pathway.
DR   Reactome; R-RNO-202424; Downstream TCR signaling.
DR   Reactome; R-RNO-2871837; FCERI mediated NF-kB activation.
DR   Reactome; R-RNO-450302; activated TAK1 mediates p38 MAPK activation.
DR   Reactome; R-RNO-450321; JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1.
DR   Reactome; R-RNO-5357956; TNFR1-induced NF-kappa-B signaling pathway.
DR   Reactome; R-RNO-5607764; CLEC7A (Dectin-1) signaling.
DR   Reactome; R-RNO-9020702; Interleukin-1 signaling.
DR   Reactome; R-RNO-937042; IRAK2 mediated activation of TAK1 complex.
DR   Reactome; R-RNO-937072; TRAF6-mediated induction of TAK1 complex within TLR4 complex.
DR   Reactome; R-RNO-9645460; Alpha-protein kinase 1 signaling pathway.
DR   Reactome; R-RNO-975163; IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation.
DR   PRO; PR:Q5U303; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000016054; Expressed in skeletal muscle tissue and 19 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0010008; C:endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005765; C:lysosomal membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0070530; F:K63-linked polyubiquitin modification-dependent protein binding; ISS:UniProtKB.
DR   GO; GO:0060090; F:molecular adaptor activity; ISO:RGD.
DR   GO; GO:0043130; F:ubiquitin binding; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; ISS:UniProtKB.
DR   GO; GO:0042742; P:defense response to bacterium; ISO:RGD.
DR   GO; GO:0007507; P:heart development; ISS:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; ISO:RGD.
DR   GO; GO:0038061; P:non-canonical NF-kappaB signal transduction; ISO:RGD.
DR   GO; GO:0043123; P:positive regulation of canonical NF-kappaB signal transduction; ISS:UniProtKB.
DR   GO; GO:0045860; P:positive regulation of protein kinase activity; ISS:UniProtKB.
DR   GO; GO:0032496; P:response to lipopolysaccharide; ISO:RGD.
DR   CDD; cd14362; CUE_TAB2_TAB3; 1.
DR   Gene3D; 1.10.8.10; DNA helicase RuvA subunit, C-terminal domain; 1.
DR   Gene3D; 2.30.30.380; Zn-finger domain of Sec23/24; 1.
DR   InterPro; IPR003892; CUE.
DR   InterPro; IPR041911; TAB2/3_CUE.
DR   InterPro; IPR001876; Znf_RanBP2.
DR   InterPro; IPR036443; Znf_RanBP2_sf.
DR   PANTHER; PTHR46253:SF2; TGF-BETA-ACTIVATED KINASE 1 AND MAP3K7-BINDING PROTEIN 2; 1.
DR   PANTHER; PTHR46253; TGF-BETA-ACTIVATED KINASE 1 AND MAP3K7-BINDING PROTEIN TAB; 1.
DR   Pfam; PF02845; CUE; 1.
DR   SMART; SM00546; CUE; 1.
DR   SMART; SM00547; ZnF_RBZ; 1.
DR   SUPFAM; SSF90209; Ran binding protein zinc finger-like; 1.
DR   PROSITE; PS51140; CUE; 1.
DR   PROSITE; PS01358; ZF_RANBP2_1; 1.
DR   PROSITE; PS50199; ZF_RANBP2_2; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Coiled coil; Cytoplasm; Endosome; Isopeptide bond;
KW   Lysosome; Membrane; Metal-binding; Methylation; Phosphoprotein;
KW   Reference proteome; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..693
FT                   /note="TGF-beta-activated kinase 1 and MAP3K7-binding
FT                   protein 2"
FT                   /id="PRO_0000225697"
FT   DOMAIN          8..51
FT                   /note="CUE"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00468"
FT   ZN_FING         663..693
FT                   /note="RanBP2-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00322"
FT   REGION          90..117
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          224..310
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          330..361
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          564..583
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          640..663
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          675..685
FT                   /note="Interaction with polyubiquitin"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NYJ8"
FT   COILED          532..619
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        649..663
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         173
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NYJ8"
FT   MOD_RES         372
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NYJ8"
FT   MOD_RES         450
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NYJ8"
FT   MOD_RES         482
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NYJ8"
FT   MOD_RES         524
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NYJ8"
FT   MOD_RES         582
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NYJ8"
FT   CROSSLNK        329
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NYJ8"
FT   CROSSLNK        562
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NYJ8"
FT   CROSSLNK        611
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NYJ8"
FT   VAR_SEQ         621..693
FT                   /note="PHFNPSAIHNFYDNIGFVGPVPPKPKDQRSTIKAPKTQDTEDEEGAQWNCTA
FT                   CTFLNHPALIRCEQCEMPRHF -> KVQCILS (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_017421"
SQ   SEQUENCE   693 AA;  76328 MW;  2458318BAA02C0B4 CRC64;
     MAQGSHQIDF QVLHDLRQKF PEVPEVVVSR CMLQNNNNLD ACCAVLSQES TRYLYGEGDL
     NFSDESGISG LRNHMTSLNL DLQSQNVYHH GREGSRVNGS RTLTHSVSDG QLQGGQSNNE
     LFQQEPQTAP AQVPQGFNVF GMPSTSGASN STPHLGFHLG SKGTSNLSQQ TPRFNPIMVT
     LAPNIQTGRS TPTSLHIHGV PPPVLNSPQG NSIYIRPYIT TPSGAARQTQ QHSGWVSQFN
     PVNPQQAYQP SQPGPWTTYP ASNPLPHTST QQPNQQGHQT SHVYMPISSP TTPQPPTVHS
     SASSQSSAHS QYNIQNISTG PRKNQIEIKL EPPQRNSSSK LRSSGPRTAS TSSLVNSQTL
     NRNQPTVYIA ASPPSTDEMI SRSQPKVYIS ANASTGDEQG MRNQPTLFIS TNSGASAASR
     NMSGQVSMGP AFIHHHPPKS RVLGGNSAAS PRVVVTQPNT KYTFKITVSP NKPPAVSPGV
     VSPTFELTNL LNHPDHYVET ETIQHLTDPT LAHVDRVSEA RKLSMGSDDA AYTQALLVHQ
     KARMERLQRE LEMQKKKLDK LKSEVNEMEN SLTRRRLKRS NSMSQIPSLE EMQQLRSCNR
     QLQIDIDCLT KEIDLFQARG PHFNPSAIHN FYDNIGFVGP VPPKPKDQRS TIKAPKTQDT
     EDEEGAQWNC TACTFLNHPA LIRCEQCEMP RHF
//
